Low-contrast acuity measures visual improvement in phase 3 trial of natalizumab in relapsing MS

L.J. Balcer, S.L. Galetta, C.H. Polman, E. Eggenberger, P.A. Calabresi, A. Zhang, J.V. Scanlon, R. Hyde

Research output: Contribution to journalArticleAcademicpeer-review

44 Citations (Scopus)
Original languageEnglish
Pages (from-to)119-124
JournalJournal of the neurological sciences
Issue number1-2
Publication statusPublished - 2012

Cite this